Effect of model microgravity on human hepatic pharmacokinetics and urea secretion

机译：模型微重力对人肝药代动力学和尿素分泌的影响

获取原文

获取原文并翻译 | 示例

页面导航

摘要
著录项
相似文献
相关主题

摘要

3-Dimensional hepatocyte aggregates experience simulated microgravity in a Rotary Cell Culture System (RCCS). Pharmacokinetic rate and urea secretion are up-regulated in model microgravity. This work has application to space life sciences and clinical dosing requirements for long term manned space exploration.

机译：3维肝细胞聚集体在旋转细胞培养系统（RCCS）中经历了模拟的微重力作用。模型微重力下的药代动力学速率和尿素分泌被上调。这项工作已应用于太空生命科学和长期载人太空探索的临床剂量要求。

著录项

来源
《Bioengineering Conference (NEBEC), 2012 38th Annual Northeast》|2012年|p.171- 172|共2页
会议地点 Philadelphia PA(US)
作者
Snyder J. E.; Emami K.; Du B.; Zhang Y.; Wu H.; Sun W.;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种 eng
中图分类生物工程学（生物技术）;
关键词

相似文献

外文文献
中文文献
专利

1. Physiologically based pharmacokinetic-pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans [J] . Kong Wei-min, Sun Bin-bin, Wang Zhong-jian, International journal of sports medicine . 2020,第6期

机译：基于生理基础的药代动力学 - 药代动力学模型，用于预测脊柱醛药代动力学及其对大鼠，狗和人类静脉/口服施用后胃酸分泌的抑制作用
2. Physiologically based pharmacokinetic-pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans [J] . Wei-min Kong, Ru-jun Xu, Ping Li, 中国药理学报：英文版 . 2020,第006期
3. Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans. [J] . Yun HY, Park HC, Kang W, Journal of Clinical Pharmacy and Therapeutics . 2006,第5期

机译：格列美脲对健康人胰岛素分泌和葡萄糖降低的影响的药代动力学和药效学模型。
4. Effect of model microgravity on human hepatic pharmacokinetics and urea secretion [C] . Snyder J. E., Emami K., Du B., Annual Northeast Bioengineering Conference . 2012

机译：微粒模型对人类肝药代动力学和尿素分泌的影响
5. Integration of preclinical and clinical data with pharmacokinetic modeling and simulations to characterize the disposition of orally-active antiparasitic prodrugs and metabolites: Prediction of the dose-exposure relationship in humans. [D] . Yan, Zhixia. 2011

机译：临床前和临床数据与药代动力学建模和模拟的集成，以表征口服活性抗寄生虫前药和代谢物的分布：预测人类的剂量-暴露关系。
6. Physiologically based pharmacokinetic–pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats dogs and humans [O] . Wei-min Kong, Bin-bin Sun, Zhong-jian Wang, 2020

机译：基于生理基础的药代动力学药物动力学模型用于预测脊代药代动力学及其对大鼠狗和人类静脉/口服施用后胃酸分泌的抑制作用
7. Human Plasma Concentrations of Tolbutamide and Acetaminophen Extrapolated from in vivo Animal Pharmacokinetics Using in vitro Human Hepatic Clearances and Simple Physiologically Based Pharmacokinetic Modeling for Radio-labeled Microdose Clinical Studies [O] . Hiroshi YAMAZAKI, Eriko KUNIKANE, Sayako NISHIYAMA, 2015

机译：人体血浆浓度与乙酰丁胺烯烃的甲醛和乙酰氨基酚在体内的甲酰胺中外推，使用在体外的人肝脏间隙和用于无线标记微孔临床研究的简单生理学药代动力学建模

Effect of model microgravity on human hepatic pharmacokinetics and urea secretion

摘要

著录项

相似文献

相关主题

期刊订阅